Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Bethesda, MD, 20892-7004, USA.
Office of the Dean, College of Health and Human Services, George Mason University, Fairfax, VA, USA.
Clin Epigenetics. 2020 Jul 11;12(1):103. doi: 10.1186/s13148-020-00894-6.
Prenatal maternal plasma persistent organic pollutant (POP) concentrations have been associated with neonatal outcomes. However, the underlying mechanisms remain unknown. Placental epigenetic mechanisms may be involved, but no prior epigenome-wide studies have investigated the impact of maternal POPs on placental DNA methylation. We studied the association between maternal plasma POP concentration in early pregnancy and epigenome-wide placental DNA methylation among 260 pregnant women from the NICHD Fetal Growth Studies.
Our analysis focused on POPs with more than 80% plasma concentrations above the limit of quantification, including 3 organochlorine pesticides (hexachlorobenzene, trans-nonachlor, p,p'-dichlorodiphenyldichloroethylene), 1 polybrominated diphenyl ether (PBDE 47), 3 polychlorinated biphenyls (138/158, 153, 180), and 6 poly- and perfluorinated alkyl substances (PFASs) (perfluorodecanoic acid, perfluorohexanesulfonic acid, perfluorononanoic acid, perfluorooctanesulfonic acid, perfluoroundecanoic acid (PFUnDA)). Using 5% false discovery rate, POPs were associated with a total of 214 differentially methylated CpG sites (nominal p values ranging from 2.61 × 10 to 2.11 × 10). Out of the 214 CpG sites, 24 (11%) were significantly correlated with placental expression of 21 genes. Notably, higher PFUnDA was associated with increased methylation at 3 CpG sites (cg13996963, cg12089439, cg18145877) annotated to TUSC3, and increased methylation at those 3 CpG sites was correlated with decreased expression of TUSC3 in the placenta. Increased methylation at cg18145877 (TUSC3) and decreased expression of TUSC3 were correlated with shorter birth length. Out of the 214 CpG sites, methylation at 44 CpG sites was correlated (p value < 0.10) with at least one neonatal anthropometry measure (i.e., birth weight, birth length, and head circumference). Seven CpG sites mediated (p value < 0.05) the association between PBDE 47 and neonatal anthropometry measures. Genes annotating the top differentially methylated CpG sites were enriched in pathways related to differentiation of embryonic cells (PBDE 47) and in pathways related to brain size and brain morphology (PFASs).
DNA methylation changes in the placenta were significantly associated with maternal plasma POPs concentration. The findings suggest that placental DNA methylation and gene expression mechanism may be involved in the prenatal toxicity of POPs and their association with neonatal anthropometry measures.
产前母体血浆持久性有机污染物(POP)浓度与新生儿结局有关。然而,其潜在机制尚不清楚。胎盘表观遗传机制可能参与其中,但以前没有全基因组的研究调查过母体 POP 对胎盘 DNA 甲基化的影响。我们研究了 260 名来自 NICHD 胎儿生长研究的孕妇妊娠早期母体血浆 POP 浓度与全基因组胎盘 DNA 甲基化之间的关系。
我们的分析主要集中在血浆浓度超过定量限 80%以上的 POP 上,包括 3 种有机氯农药(六氯苯、反式-非六氯、p,p'-二氯二苯二氯乙烯)、1 种多溴二苯醚(PBDE 47)、3 种多氯联苯(138/158、153、180)和 6 种多氟和全氟烷基物质(PFASs)(全氟癸酸、全氟己烷磺酸、全氟壬酸、全氟辛烷磺酸、全氟十一烷酸(PFUnDA))。使用 5%的错误发现率,POP 与总共 214 个差异甲基化 CpG 位点相关(名义 p 值范围从 2.61×10 到 2.11×10)。在 214 个 CpG 位点中,有 24 个(11%)与 21 个基因的胎盘表达显著相关。值得注意的是,PFUnDA 水平升高与 TUSC3 中 3 个 CpG 位点(cg13996963、cg12089439、cg18145877)的甲基化增加有关,而这些 3 个 CpG 位点的甲基化与 TUSC3 在胎盘中的表达降低有关。cg18145877(TUSC3)的甲基化增加和 TUSC3 的表达降低与出生长度较短有关。在 214 个 CpG 位点中,44 个 CpG 位点的甲基化与至少一个新生儿人体测量指标(即出生体重、出生长度和头围)相关(p 值<0.10)。44 个 CpG 位点中的 7 个与 PBDE 47 和新生儿人体测量指标之间的关联存在中介作用(p 值<0.05)。注释顶级差异甲基化 CpG 位点的基因在与胚胎细胞分化(PBDE 47)和与大脑大小和脑形态相关的途径中富集(PFASs)。
胎盘 DNA 甲基化的变化与母体血浆 POP 浓度显著相关。研究结果表明,胎盘 DNA 甲基化和基因表达机制可能参与了 POP 的产前毒性及其与新生儿人体测量指标的关系。